RAC 5.44% $1.65 race oncology ltd

Ann: Bisantrene shows potent anticancer activity in AML models

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.